Business Context and Reporting Period
This Form 8-K is a current report filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on April 17, 2024. The filing discloses two material events: a change in the company's independent registered public accounting firm and a significant development in ongoing litigation regarding directors' and officers' insurance coverage.
Key Financial Metrics and Liquidity
The filing does not provide comprehensive financial statements, revenue, profit, or debt metrics. However, it discloses specific cash flow impacts related to litigation:
- Insurance Reimbursement: On April 16, 2024, the company received a payment of $2.27 million from AmTrust International Underwriters DAC.
- Net Proceeds: After deducting attorney's fees, the company retained $1.5 million from the reimbursement.
- Going Concern: Previous audit reports for the years ended December 31, 2023, and 2022, disclosed an uncertainty regarding the company's ability to continue as a going concern.
Material Changes
Change in Certifying Accountant
- Dismissal: Marcum LLP was dismissed as the independent registered public accounting firm effective immediately on April 17, 2024.
- Engagement: M&K CPA's, PLLC was engaged as the new independent registered public accounting firm for the fiscal year ending December 31, 2024, effective immediately.
- Reasoning: The filing states there were no disagreements with Marcum regarding accounting principles or auditing scope. The only qualification in prior reports was the "going concern" uncertainty.
Litigation Resolution (Partial)
- The company received a partial victory in its declaratory relief action against AmTrust and Freedom Specialty Insurance Company regarding D&O insurance coverage.
- A court order issued on April 21, 2023, ruled in the company's favor on three major issues, including that the company is an insured under the policies and that certain SEC subpoena expenses are covered.
- The dispute regarding the "Change in Control" exclusion remains unresolved and is pending trial.
Outlook, Risks, and Management Commentary
- Litigation Risk: Management believes it has a strong case but acknowledges there can be no assurance of prevailing on the remaining "Change in Control" issue.
- Financial Risk: The prior "going concern" uncertainty noted by the former auditor suggests ongoing liquidity or operational challenges, though the recent $1.5 million net cash inflow provides immediate relief.
- Management Stance: The company intends to "vigorously pursue" the final matter to establish entitlement to full payment of advanced expenses from both insurers.
Investor Verification Checklist
- Verify the status of the "going concern" uncertainty in the most recent 10-K or 10-Q filings to assess current liquidity risks.
- Confirm the timeline for the trial regarding the "Change in Control" exclusion in the insurance litigation.
- Review the letter from Marcum LLP (Exhibit 16.1) to ensure no undisclosed disagreements exist regarding the change in auditors.
- Monitor future filings for the appointment of a new auditor's initial report and any restatements of prior financials.